World's Best Scientists 2026 revealed!

Overview

H. Suryapranata is affiliated with Radboud University Medical Center in the Netherlands. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions within subfields such as Genetics, Oncology, Pathology and Forensic Medicine, Molecular Biology, and Cancer Research.

Their work extensively covers topics related to colorectal cancer, including genetic factors, genetic associations and epidemiology, colorectal cancer screening and detection, as well as aspects concerning cancer, lipids, and metabolism. Additional areas of study involve cancer genomics and diagnostics, colorectal cancer treatments, and the role of gut microbiota in health.

H. Suryapranata has published research spanning multiple venues, with frequent publications in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancer Research
  • Cancer Epidemiology Biomarkers & Prevention
  • Nature Communications
  • American Journal of Clinical Nutrition

Their recent papers include:

  • "Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis," 2020, Nature Communications
  • "Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk," 2020, The American Journal of Human Genetics
  • "Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries," 2022, Nature Genetics
  • "Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study," 2020, BMC Medicine
  • "Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival," 2020, Nature Communications

Frequent collaborators of H. Suryapranata include:

  • Hermann Brenner
  • Michael Hoffmeister
  • Marc J. Gunter
  • Stefanie Brezina
  • Tabitha A. Harrison

The main scientific topics covered by H. Suryapranata's research demonstrate a strong focus on understanding genetic risk factors in colorectal cancer and its epidemiology alongside investigations into disease screening, diagnostics, and metabolic influences. Their multidisciplinary approach integrates molecular biology techniques and epidemiological data to explore cancer biology and potential clinical implications.

Best Publications

  • Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction Every Minute of Delay Counts

    Giuseppe De Luca;Harry Suryapranata;Jan Paul Ottervanger;Elliott M. Antman

  • A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction.

    F. Zijlstra;M. J. De Boer;J. C. A. Hoorntje;S. Reiffers

  • Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.

    Giuseppe De Luca;Harry Suryapranata;Gregg W. Stone;David Antoniucci

  • Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial

    Arnoud Wj van't Hof;Jurriën ten Berg;Ton Heestermans;Thorsten Dill

  • Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty.

    Giuseppe De Luca;Harry Suryapranata;Felix Zijlstra;Arnoud W J van 't Hof

  • Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.

    Daniel J F M Thuijs;A Pieter Kappetein;Patrick W Serruys;Friedrich-Wilhelm Mohr

  • Angiographic Assessment of Reperfusion in Acute Myocardial Infarction by Myocardial Blush Grade

    Jose P.S. Henriques;Felix Zijlstra;Arnoud W.J. van ‘t Hof;Menko-Jan de Boer

  • PexeLizumab for Acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: A randomized controlled trial

    Paul W. Armstrong;N. Bett;D. Brieger;D. Chew

  • The Na^+/H^+ exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction : Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial

    Uwe Zeymer;Harry Suryapranata;Jean Pierre Monassier;Grzegorz Opolski

  • Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up.

    P J de Feyter;M van den Brand;G J Laarman;R van Domburg

  • Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy.

    Menko-Jan de Boer;Jan-Paul Ottervanger;Arnoud W J van 't Hof;Jan C A Hoorntje

  • Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: The glucose-insulin-potassium study: a randomized trial☆

    Iwan C.C. van der Horst;Felix Zijlstra;Arnoud W.J. van 't Hof;Catharina Jacoba Maria Doggen

  • Prognostic Assessment of Patients With Acute Myocardial Infarction Treated With Primary Angioplasty Implications for Early Discharge

    Giuseppe De Luca;Harry Suryapranata;Arnoud W J van 't Hof;Menko-Jan de Boer

  • Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study Group.

    Carlos Miguel;Patrick Serruys;Peter Ruygrok;Harry Suryapranata

  • The effect of completeness of revascularization on event-free survival at one year in the arts trial

    Marcel J.B.M van den Brand;Benno J.W.M Rensing;Marie-angèle M Morel;David P Foley

  • Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty.

    Giuseppe De Luca;Arnoud W J van 't Hof;Menko-Jan de Boer;Jan Paul Ottervanger

  • Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial.

    Arnoud W. J. van 't Hof;Nicolette Ernst;Menko-Jan de Boer;Rob de Winter

  • Drug-Eluting vs Bare-Metal Stents in Primary Angioplasty: A Pooled Patient-Level Meta-analysis of Randomized Trials

    Giuseppe De Luca;Maurits T. Dirksen;Christian Spaulding;Henning Kelbæk

  • Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis

    Eliano Pio Navarese;Kenneth Tandjung;Bimmer Claessen;Felicita Andreotti

  • Long-Term Benefit of Primary Angioplasty as Compared with Thrombolytic Therapy for Acute Myocardial Infarction

    Felix Zijlstra;Jan C.A. Hoorntje;Menko-Jan De Boer;Stoffer Reifers

Frequent Co-Authors

Patrick W. Serruys
Patrick W. Serruys University of Galway
Pim J. de Feyter
Pim J. de Feyter Erasmus University Rotterdam
Petr Widimsky
Petr Widimsky Charles University
Alec Vahanian
Alec Vahanian Université Paris Cité
Ron T. van Domburg
Ron T. van Domburg Erasmus University Rotterdam
Johan H. C. Reiber
Johan H. C. Reiber Leiden University Medical Center
Felix Zijlstra
Felix Zijlstra Erasmus University Rotterdam
Peter de Jaegere
Peter de Jaegere Erasmus University Rotterdam
Jos R.T.C. Roelandt
Jos R.T.C. Roelandt Erasmus University Rotterdam
Keith D. Dawkins
Keith D. Dawkins Boston Scientific (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The field of Medicine in the USA offers a range of online degrees for students interested in healthcare careers beyond traditional medical school. With the growing demand for healthcare professionals, many accredited institutions now provide flexible options to earn advanced degrees from home.

For aspiring healthcare leaders, pursuing an affordable mha online can open doors to administrative roles in hospitals and clinics. Those interested in advanced nursing practice may consider enrolling in one of the best dnp programs online to achieve a Doctor of Nursing Practice degree.

Pharmacists looking for more flexibility can pursue an online pharmacist degree, which allows for continuing education without pausing professional commitments. Additionally, a him associate degree online can prepare students for careers in managing vital health records and information systems.

These pathways provide accessible options for those seeking to advance or pivot their healthcare careers with the convenience of online learning.

Best Scientists Citing H. Suryapranata

Trending Scientists